Principal Recipients (PR) may have several responsibilities under AMFm Phase 1. Firstly, the Principal Recipient nominated for AMFm Phase 1 is responsible for managing, monitoring and reporting on AMFm supporting interventions implemented through the AMFm ‘host’ grant.
A PR may also be a first-line buyer for AMFm, if the grant for which they are responsible includes a procurement component for artemisinin-based combination therapies (ACTs). In order to be a first-line buyer for AMFm, a PR must sign the non-negotiable first-line buyer undertaking with the Global Fund. This undertaking is in addition to any existing agreements the PR currently has as part of its grant agreement with the Global Fund.
Contact | Legal | RSS | Sitemap
© 2013 The Global Fund to Fight AIDS, Tuberculosis and Malaria